NDC11 00093729056
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00093-7290-56 | 00093-7290 |
| 0093-7290-56 | 0093-7290 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Raloxifene Hydrochloride | RALOXIFENE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | e6be5b1d-757d-4bab-ad6a-c421960a104d | 2021-08-31 | Boxed warning, Warnings, Adverse reactions | 0093-7290-56 0093-7290 00093729056 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.